Tran submitted preliminary topline results of NA-931 allegedly gathered from a Phase 2, 13-week randomized trial ( live , archived ): The 13-week MAD study showed NA-931 demonstrated dose-dependent reductions in mean body weight from baseline, up to 14.8 % at 150 mg daily dosage, or 13.2% % [sic] relative to placebo No muscle loss was observed
Another peptide, GHK-Cu, is being studied for potential cosmetic benefits such as for photoaging and hair loss and was added to the Category 1 list (but not for injectable routes of administration)
Supplements that influence blood sugar should also be used with caution
The right next step depends on how much weight you still need to lose, your current health status, and what youre willing to commit to
While it enjoyed increasing medical use, particularly in patients with certain heart conditions, scientists and early adopters in sport were less impressed